NVDA insider sale: 75,000 shares scheduled for 10/09/2025
NVIDIA Corporation insider notice reports planned and recent sales of common stock by Jen Hsun Huang.
Rhea-AI Filing Summary
NVIDIA Corporation insider notice reports planned and recent sales of common stock by Jen Hsun Huang. The filing lists a proposed sale of 75,000 shares to be executed through Charles Schwab on 10/09/2025 with an aggregate market value of 14,491,151.00 and shows total shares outstanding of 24,300,000,000. The securities to be sold were acquired on 03/17/2021 through a performance stock lapse and were held as equity compensation.
The filing also discloses numerous completed sales of 75,000 shares each between 07/09/2025 and 10/08/2025, with individual gross proceeds ranging roughly from 12,233,616.00 to 14,199,272.00. The signer certifies no undisclosed material adverse information and references Rule 10b5-1 language for trading plans.
Positive
- Transparent disclosure of multiple sales with dates and gross proceeds provides clear market information
- Securities originated from equity compensation (performance stock lapse dated 03/17/2021), not open-market purchases tied to recent insider information
Negative
- Substantial insider selling activity with many 75,000-share blocks between 07/09/2025 and 10/08/2025, which could contribute to additional share supply
- No explicit 10b5-1 plan adoption date is provided in the filing text, leaving uncertainty whether sales are pre-scheduled
Insights
Insider is executing scheduled equity-compensation sales across mid-2025 to 10/09/2025.
The pattern of repeated 75,000-share transactions suggests systematic disposition of vested equity that originated from a performance stock lapse on 03/17/2021. Sales were routed through Charles Schwab & Co. and include a proposed sale on 10/09/2025 valued at 14,491,151.00.
These transactions reduce the insider's holding incrementally but, against a total share count of 24,300,000,000, each block is immaterial to company capitalization. Watch for any explicit 10b5-1 adoption date or plan language to confirm whether sales are pre-planned; absent that date, contemporaneous certification is the primary disclosure provided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the NVDA Form 144 filed for Jen Hsun Huang disclose?
What is the size of each sale block reported for NVDA insider sales?
Do the filings state whether a Rule 10b5-1 trading plan was used?
AI-generated analysis. How Rhea-AI works. Not financial advice.